ArticleMolecular therapy. Nucleic acids2026

Delivery of monoclonal antibodies using mRNA lipid nanoparticles confers protection against SARS-CoV-2 and influenza.

Mai N Vu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.